News Articles
WBFO Interviews Dr. Janet Morrow
Ferric Contrast Wins $750,000 NSF Grant
Ferric Contrast has been awarded a National Science Foundation STTR Phase II grant for $750,000. The grant will further commercialzation of our iron-based MRI contarst agents.
Ferric Contrast Gets Invited to Homecoming
Ferric Contrast Goes to Washington
Ferric Contrast Selected to Represent American Assocication of Universities and Association of Public Land-Grant Universities at Capitol Hill Event
Ferric Contrast is a Semi-Finalist
FDA Safety Communication
Researchers Link Brain Tumors to Gadolinium Deposits
Safety Issues Linger Over Gadolinium Based Contrast
Ferric Contrast to Exhibit at Bright Buffalo Niagara
Come by our booth May 2 at the historic Hotel Henry and see how we are making MRI imaging safer.
Ferric Contrast Awarded from Bruce Holm Fund
Study Finds Gadolinium in Bone
Canadian Researchers Find Residual MRI Contrast Agent in Tissue
Ferric Contrast Receives $225,000 NSF STTR Award
Ferric Contrast, Inc. wins competitive National Science Foundation STTR award to advance R&D on novel MRI contrast agents.
WBEN Buffalo Business Report
Ferric Contrast wins $50,000 at 2017 FuzeHub Commercialization Competition in Albany
Two UB startups win $50,000 in FuzeHub commercialization competition
“This funding will help these companies advance their commercialization strategies, which was one of the major objectives of the competition.”
Elena Garuc, executive director
FuzeHub